NLS Pharmaceutics AG logo

NLS Pharmaceutics AG NLSP

$ 4.26 18.33%

Annual report 2023
added 10-19-2024

report update icon

Country

schweizSchweiz

IPO year

2021

Industry

-

Stock Exchange

NASDAQ GLOBAL

CEO

-

Employees in the company

-

Shares

38.2 M

Market Cap[1]

$ 163 M

EBITDA (LTM)

-

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.